Skip to content

A clinical trial to see the effects of Astangalavana & Srikhandasava in Patients with Madatyaya (Alcohol dependence)

Effectiveness of the role of Astangalavana and Srikhandasava as add on treatment on Madatyaya (Alcohol dependence) - an open level clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021831
Enrollment
200
Registered
2019-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Astangalavana srikhandasava: 1. Astanga Lavana (B.R /Madatyaya/15-16, AFI Part-II, 7:3) Dose : 3 gm twice daily Dosage form : Choornam Route of Administration : Oral Time of Adm

Sponsors

Central Council For Research In Ayurvedic SciencesCCRAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male Patient with age group of 18 to 60 years. 2. Patients who meet ICD-10 criteria for Alcohol dependence 3. Willing to participate for 3 months

Exclusion criteria

Exclusion criteria: 1. Patients suffering from any Organic brain disorder. 2. Patients suffering from major complications of Alcohol related disorders like Hepatitis, Cirrhosis of the liver etc. defined as 5 times increase in liver enzymes i.e. AST and ALT 3. Patients having the H/O concomitant other substance abuse except Nicotine/Caffeine 4. Patients suffering with other significant Systemic illness including Hyper Tension / Suicidal tendency 5. All psychiatry illness will be excluded by screening with MSE (Mental Status Examination)

Design outcomes

Primary

MeasureTime frame
% days abstinent [Time frame:12weeks]- % days without any alcohol consumption over the treatment period assessed by Alcohol Time Line Follow Backup (TLFB), Urine Etg / Ets & Breath AnalyzerTimepoint: 3months

Secondary

MeasureTime frame
1.Any changes in Liver function tests i.e. GGT (Gamma Glutamyl Transferase) as biomarkers for recent drinking. 2.Any changes in Alcohol craving questionnaire (Penn�s craving scale, Annexure-III) scores from base line to end of treatment. 3.Improvement in Quality of life before and after treatment (WHOQOL-BREF) (Annexure-IV) Timepoint: 3 months

Countries

India

Contacts

Public ContactSrinibash Sahoo

Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi

srinibash1970@gmail.com08026995323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026